JP Morgan Chase’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-41,900
| Closed | -$14.7M | – | 7630 |
|
|
2025
Q4 | $14.7M | Sell |
41,900
-4,000
| -9% | -$1.35M | ﹤0.01% | 2335 |
|
|
2025
Q3 | $14.8M | Buy |
45,900
+34,000
| +286% | +$10.6M | ﹤0.01% | 2357 |
|
|
2025
Q2 | $4.63M | Sell |
11,900
-39,400
| -77% | -$15.8M | ﹤0.01% | 3251 |
|
|
2025
Q1 | $22.3M | Sell |
51,300
-15,100
| -23% | -$6.06M | ﹤0.01% | 1845 |
|
|
2024
Q4 | $24.5M | Buy |
66,400
+36,600
| +123% | +$15.3M | ﹤0.01% | 1849 |
|
|
2024
Q3 | $15.5M | Sell |
29,800
-5,100
| -15% | -$2.72M | ﹤0.01% | 2217 |
|
|
2024
Q2 | $18.9M | Buy |
34,900
+9,500
| +37% | +$5.02M | ﹤0.01% | 1907 |
|
|
2024
Q1 | $13.2M | Buy |
25,400
+10,400
| +69% | +$5.17M | ﹤0.01% | 2238 |
|
|
2023
Q4 | $7.07M | Buy |
15,000
+3,200
| +27% | +$1.48M | ﹤0.01% | 2795 |
|
|
2023
Q3 | $5.14M | Buy |
11,800
+500
| +4% | +$227K | ﹤0.01% | 2829 |
|
|
2023
Q2 | $5.02M | Buy |
11,300
+7,800
| +223% | +$3.6M | ﹤0.01% | 2857 |
|
|
2023
Q1 | $1.61M | Hold |
3,500
| – | – | ﹤0.01% | 3690 |
|
|
2022
Q4 | $1.79M | Buy |
3,500
+1,500
| +75% | +$762K | ﹤0.01% | 3643 |
|
|
2022
Q3 | $908K | Hold |
2,000
| – | – | ﹤0.01% | 4072 |
|
|
2022
Q2 | $965K | Buy |
+2,000
| New | +$989K | ﹤0.01% | 4125 |
|
|
2020
Q1 | – | Sell |
-24,800
| Closed | -$7.49M | – | 5393 |
|
|
2019
Q4 | $7.49M | Hold |
24,800
| – | – | ﹤0.01% | 2367 |
|
|
2019
Q3 | $5.95M | Hold |
24,800
| – | – | ﹤0.01% | 2554 |
|
|
2019
Q2 | $7M | Sell |
24,800
-38,500
| -61% | -$10.5M | ﹤0.01% | 2375 |
|
|
2019
Q1 | $18.2M | Sell |
63,300
-15,700
| -20% | -$4.54M | ﹤0.01% | 1603 |
|
|
2018
Q4 | $20.7M | Buy |
79,000
+16,300
| +26% | +$4.48M | ﹤0.01% | 1460 |
|
|
2018
Q3 | $17.2M | Sell |
62,700
-33,400
| -35% | -$8.67M | ﹤0.01% | 1783 |
|
|
2018
Q2 | $22.9M | Buy |
96,100
+91,600
| +2,036% | +$21.2M | ﹤0.01% | 1475 |
|
|
2018
Q1 | $989K | Hold |
4,500
| – | – | ﹤0.01% | 3677 |
|
|
2017
Q4 | $1.01M | Hold |
4,500
| – | – | ﹤0.01% | 3723 |
|
|
2017
Q3 | $854K | Buy |
+4,500
| New | +$856K | ﹤0.01% | 3592 |
|
|
2016
Q2 | – | Sell |
-40,000
| Closed | -$5.56M | – | 4824 |
|
|
2016
Q1 | $5.56M | Sell |
40,000
-1,800
| -4% | -$241K | ﹤0.01% | 2146 |
|
|
2015
Q4 | $5.83M | Sell |
41,800
-13,200
| -24% | -$1.82M | ﹤0.01% | 2126 |
|
|
2015
Q3 | $7.7M | Sell |
55,000
-2,947,860
| -98% | -$443M | ﹤0.01% | 1948 |
|
|
2015
Q2 | $493M | Buy |
3,002,860
+2,002,860
| +200% | +$320M | 0.12% | 194 |
|
|
2015
Q1 | $154M | Buy |
1,000,000
+815,400
| +442% | +$116M | 0.04% | 491 |
|
|
2014
Q4 | $23.2M | Sell |
184,600
-2,700
| -1% | -$334K | 0.01% | 1379 |
|
|
2014
Q3 | $22.4M | Sell |
187,300
-154,700
| -45% | -$17.7M | 0.01% | 1380 |
|
|
2014
Q2 | $36.8M | Buy |
+342,000
| New | +$35.2M | 0.01% | 1009 |
|
Other funds holding ELV
VCM
VPM
JP Morgan Chase's ELV Position: Q1 2026 in Review
JP Morgan Chase increased its Elevance Health (ELV) stake by 4.1% in Q1 2026, buying an estimated $13.8M and bringing the position to 1,069,955 shares worth $305M. The position accounts for 0.02% of the portfolio, ranked #549.
JP Morgan Chase first reported a position in ELV in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.31B in Q3 2024. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.
- JP Morgan Chase held 1,069,955 shares of Elevance Health worth $305M as of Q1 2026.
- JP Morgan Chase bought 42,071 Elevance Health shares in Q1 2026, an estimated $13.8M.
- Elevance Health made up 0.02% of JP Morgan Chase's portfolio in Q1 2026, its #549 holding.
- JP Morgan Chase first reported a position in Elevance Health in Q2 2013 and has held it in 52 quarters since.
- JP Morgan Chase's Elevance Health position peaked at $1.31B in Q3 2024.
- 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.
Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.